*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>Moxifloxacin EP Impurity A</strong> is a critical reference standard used in the pharmaceutical industry to ensure the quality of Moxifloxacin hydrochloride. It is primarily synthesized as a by-product during the manufacturing process of the active pharmaceutical ingredient. The compound serves as an essential tool for method development and validation under European Pharmacopoeia guidelines. <strong>CAS No: 197820-45-4</strong>, <strong>Formula: C21H26FN3O4S</strong>.</p>
<h3>Application</h3>
<ul>
<li>Quality control laboratories for identifying trace impurities in bulk drug substances.</li>
<li>Method validation for HPLC systems to verify specificity and sensitivity.</li>
<li>Stability-indicating studies to monitor degradation pathways during storage.</li>
</ul>
<h3>Precautions</h3>
<p>Store strictly at controlled room temperature away from light and moisture. Handle with appropriate PPE including gloves and goggles to prevent skin contact. This material is intended solely for analytical research and not for clinical administration or therapeutic use.</p>